Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.34
-21.2 %
$ 8.12 M
Market Cap
-0.22
P/E
PRPH - TOTAL EQUITY
Total Equity PRPH - ProPhase Labs, Inc.
49.4 M
LAST VALUE
-8.22%
2 YEAR CAGR
24.51%
5 YEAR CAGR
14.64%
10 YEAR CAGR